Seoul National University Hospital
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Ovarian CancerEndometrial CancerCervical Cancer
- Interventions
- Other: Proactive immune tolerance inductionOther: Standard Treatment
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 1028
- Registration Number
- NCT06977594
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Complications of Midline Catheter in Surgical Children
Recruiting
- Conditions
- Midline Catheter
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06979167
- Locations
- π°π·
Seoul National University Children's Hospital, Seoul, Korea, Republic of
Streamlining Radioembolization for Small HCC
Not yet recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT06979219
- Locations
- π°π·
National Cancer Center, Goyang, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
Effects of Binaural Beats on Inhaled Anesthetic Requirements During General Anesthesia in Pediatric Patients
Not Applicable
Not yet recruiting
- Conditions
- General AnesthesiaChildren
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT06979206
Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model
Completed
- Conditions
- Thyroid Cancer
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 275
- Registration Number
- NCT06969768
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Effects of Deep Touch Pressure on Emergence Agitation in Pediatric Patients
Not Applicable
Not yet recruiting
- Conditions
- Deep Touch Pressure
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 94
- Registration Number
- NCT06966466
- Locations
- π°π·
Seoul National University Children's Hospital, Seoul, Korea, Republic of
The Video System to Provide a Developmental Training Guide for Preterm Infants
Not Applicable
Not yet recruiting
- Conditions
- Premature InfantsVery Low Birth Weight Infants
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06965842
- Locations
- π°π·
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Comparison of First Attempt Success in Nasotracheal Intubation Using Macintosh Videolaryngoscope vs. Flexible Bronchoscope
Not Applicable
Not yet recruiting
- Conditions
- Intubation Complication
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT06964295
Same-day Radioembolization for Large HCC
Recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT06944483
- Locations
- π°π·
National Cancer Center, Goyang, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma
Phase 2
Terminated
- Conditions
- Peripheral T-cell Lymphoma (PTCL)
- Interventions
- Drug: Decitabine with GemOxDrug: GemOx
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 17
- Registration Number
- NCT06941688
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath